Approval · Notice of Compliance 18155 · 2016
PEMETREXED: Notice of Compliance 18155
Issued June 3, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18155
- Date
- June 3, 2016
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ALIMTA (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEMETREXED | 02455498 | Approved |
| PEMETREXED | 02455528 | Approved |
Medicinal ingredients
- PEMETREXED DISODIUM 100 MG per VIAL
- PEMETREXED DISODIUM 500 MG per VIAL